
Medications
Wegovy, Zepbound, Ozempic, Mounjaro
Monthly Cost
$99-$299
Speed to Start
Moderate
FDA-Approved Meds
Est. 2002
About Teladoc Health
Teladoc Health is the largest telehealth platform in the United States, founded in 2002 and publicly traded on the NYSE. Its entry into the GLP-1 weight-management space carries a level of institutional credibility that no startup can replicate. Teladoc prescribes brand-name medications exclusively, including Wegovy, Zepbound, Ozempic, and Mounjaro, with program costs ranging from $99-$299 depending on the plan tier and whether insurance is applied.
The clinical infrastructure behind Teladoc’s GLP-1 program is arguably the most robust in the telehealth category. Patients receive access to board-certified providers, registered dietitians, and structured behavioral health support. The platform also serves employer-sponsored wellness programs, meaning millions of Americans may have access to Teladoc’s weight-management services through their workplace benefits. Spanish-speaking providers are available, expanding accessibility for Hispanic and Latino patients who are disproportionately affected by obesity and type 2 diabetes.
Teladoc’s third-party review profile is unusual. The company holds a B rating with the Better Business Bureau, consistent with a large-scale operation that handles complaints through formal channels. However, its Trustpilot rating sits at just 2.2 stars across a very small sample of 9 reviews. Our editorial team attributes this primarily to the fact that Teladoc’s massive user base does not funnel feedback through Trustpilot; the company’s internal review systems and employer program satisfaction surveys provide a more representative picture.
The brand-name-only formulary is both a strength and a limitation. Patients get FDA-approved medications with full clinical trial backing, manufacturer support programs, and insurance billing pathways. However, patients without insurance coverage for GLP-1 medications may face significantly higher out-of-pocket costs compared to compounded alternatives available through smaller telehealth platforms. Teladoc does not offer compounded GLP-1s.
Our editorial team views Teladoc Health as the institutional gold standard for telehealth-based GLP-1 prescribing. The combination of 20+ years of operational history, dietitian access, employer program integration, and brand-name-only prescribing creates a level of clinical rigor and accountability that is unmatched. The higher cost floor is the tradeoff, but for patients with insurance coverage or employer benefits, that gap narrows considerably.
At a Glance
Medications Offered
Wegovy, Zepbound, Ozempic, Mounjaro
Brand-Name
Cost & Insurance
- Monthly: $99-$299
- 6-month estimate: $594-$1,794
- Insurance: Employer / health-plan program dependent
- Self-pay: No clear national direct-to-consumer self-pay program identified
Clinical Features
- Lab testing: No
- Dietitian access: Yes
- Verified Pharmacy: N/A — Brand-name only (Wegovy, Zepbound, Ozempic, Mounjaro); employer programs
- BBB Rating: B
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: State and program dependent
- Speed: Moderate
- Spanish-speaking providers: Yes
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.













